Ahlcon Parenterals (India) Ltd

Ahlcon Parent(I) Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Ahlcon Parenterals (India) Ltd

₹ 515 -0.19%
21 Jan 2015
Company website BSE: 524448
About

Ahlcon Parenterals (India) manufactures and sells pharmaceutical preparations in India. It offers I.V. fluids, antimicrobial I.V. fluids, and eye/ear drops.

[ add key points ]
Website BSE
  • Market Cap ₹ Cr.
  • Current Price ₹ 515
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ -46.6
  • Dividend Yield 0.00 %
  • ROCE -6.75 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 5.35% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014
30.34 28.74 29.46 30.62 31.15 28.40 28.24 33.20
21.96 20.25 21.83 22.11 21.01 21.84 23.41 24.58
Operating Profit 8.38 8.49 7.63 8.51 10.14 6.56 4.83 8.62
OPM % 27.62% 29.54% 25.90% 27.79% 32.55% 23.10% 17.10% 25.96%
0.01 0.19 0.09 -0.02 0.03 0.08 0.23 0.26
Interest 0.65 0.51 0.50 0.38 0.19 0.05 0.11 0.07
Depreciation 0.91 0.87 0.85 0.87 0.85 1.09 1.09 1.08
Profit before tax 6.83 7.30 6.37 7.24 9.13 5.50 3.86 7.73
Tax % 33.67% 31.23% 41.13% 35.22% 33.95% 29.27% 26.94% 15.27%
4.53 5.02 3.75 4.69 6.03 3.89 2.82 6.55
EPS in Rs 6.29 6.97 5.21 6.51 8.37 5.40 3.92 9.10
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
46 38 50 62 79 108 120 116 118 135 150 156
33 31 36 51 66 83 85 90 110 116 131 144
Operating Profit 13 7 15 11 13 25 35 26 9 19 19 12
OPM % 29% 17% 29% 18% 17% 23% 29% 22% 7% 14% 13% 8%
0 1 0 0 1 1 0 0 0 1 4 2
Interest 2 2 2 2 4 3 2 1 17 17 27 28
Depreciation 2 2 2 3 3 4 3 5 16 16 39 33
Profit before tax 10 3 11 6 7 19 30 21 -24 -14 -43 -48
Tax % 38% 34% 35% 34% 31% 31% 35% 19% -22% 0% 0% 0%
6 2 7 4 5 13 20 17 -19 -14 -43 -48
EPS in Rs 8.51 3.14 9.94 5.96 6.94 17.87 27.08 23.64 -25.74 -19.19 -60.30 -66.07
Dividend Payout % 18% 48% 15% 25% 14% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 15%
5 Years: 5%
3 Years: 10%
TTM: 4%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -9%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Equity Capital 7 7 7 7 7 7 7 7 7 7 7 7
Reserves 20 21 27 30 34 47 66 83 64 50 7 -41
19 14 11 26 24 18 43 206 251 274 289 296
13 10 14 18 18 23 26 43 37 33 23 53
Total Liabilities 60 53 59 81 83 96 143 339 359 364 326 315
37 35 35 50 50 46 50 278 289 275 268 246
CWIP 2 2 3 2 3 8 26 3 11 27 4 3
Investments 0 0 0 0 0 0 0 0 0 0 0 0
20 15 21 28 30 41 67 58 59 61 54 67
Total Assets 60 53 59 81 83 96 143 339 359 364 326 315

Cash Flows

Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
7 6 9
-12 -0 -2
5 -6 -4
Net Cash Flow 0 -1 2

Ratios

Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Debtor Days 59 73 79 85 60 87 102 99 81 90 62 67
Inventory Days 186 118 112 120 124 96 73 125 197 140 127 181
Days Payable 131 49 96 88 83 76 74 67 57 33 102 94
Cash Conversion Cycle 114 142 95 117 101 107 100 156 221 198 86 153
Working Capital Days 79 84 68 78 65 76 78 54 53 68 65 52
ROCE % 28% 12% 29% 17% 17% 32% 34% 10% -2% 1% -5% -7%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

All

No data available.

Annual reports